APIs, Excipients, and Manufacturing eBook
Read the article:
Containing and Enhancing Potent Particles with Micronization
Read the ebook:
Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook
Containing and Enhancing Potent Particles with Micronization
A multilayered processing approach ensures safe handling and content uniformity of highly potent APIs.
KWANCHAIFT - STOCK.ADOBE.COM
Micronization is an important tool for developing new drugs, its primary advantage being that it is scalable from the early stages of development through to commercial volumes. The micronization process is both well-understood and cost-effective.
With the increased number of potent drugs in development, having the capabilities to handle and process them is becoming imperative. Development partners with the specialized expertise and infrastructure required to handle potent APIs play a key role in the supply chain of next generation medicines.
Read this article in Pharmaceutical Technology’s October 2021 APIs, Excipients, and Manufacturing eBook.
About the Author
Andy Maitland is operations and supply chain director, Catalent.
Article Details
Pharmaceutical Technology
eBook: APIs, Excipients, and Manufacturing
October 2021
Pages: 30–35
Citation
When referring to this article, please cite it as A. Maitland, “Containing and Enhancing Potent Particles with Micronization,” Pharmaceutical Technology APIs, Excipients, and Manufacturing eBook (October 2021).
Recent Videos
Related Content
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024Podcast
In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
